US2008107602A1PendingUtilityA1

Neospora caninum isolate

57
Assignee: UNIV TECHNOLOGYPriority: Jul 28, 2000Filed: Oct 31, 2007Published: May 8, 2008
Est. expiryJul 28, 2020(expired)· nominal 20-yr term from priority
Inventors:John EllisCatherine Douglas MillerHelen Quinn
A61K 2039/505A61P 33/02C12N 15/11C07K 16/20A61K 39/00C12R 2001/90C07K 14/44C12N 1/105Y02A50/30
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a novel Neospora caninum isolate from Nowra and extracts thereof. The strain is useful in the development of diagnostic assays for the detection of parasites in animals. The present invention also relates to pharmaceutical compositions, using live or killed organisms or extracts thereof, for the treatment and prevention of parasitic infections in animals.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled)  
     
     
         17 . A parasitic protozoan isolate having the characteristics of the isolate deposited as AGAL Accession No. NM01/22338.  
     
     
         18 . The host cell infected with an isolate as claimed in  claim 17 .  
     
     
         19 . The host cell as claimed in  claim 18  which is derived from the sample deposited as AGAL Accession No. NM01/22339.  
     
     
         20 . The vaccine composition comprising an isolate as claimed in  claim 17 , wherein the isolate is in the form of killed parasites or live attenuated parasites.  
     
     
         21 . The method of diagnosing a parasitic infection or disease in an animal, the method comprising detecting the presence of an isolate according to  claim 17  in the animal, or in a clinical specimen from the animal.  
     
     
         22 . The method as claimed in  claim 21  wherein the clinical specimen is selected from the group consisting of a biopsy, a stool specimen, a blood sample and foetal tissue.  
     
     
         23 . The method for the treatment or prevention of infection or disease in an animal, the method comprising administering to the animal a vaccine composition as claimed in  claim 20 .  
     
     
         24 . The method as claimed in  claim 21  wherein the infection or disease is caused by the presence of  Neospora  in the animal.  
     
     
         25 . The method as claimed in  claim 23  wherein the infection or disease is caused by the presence of  Neospora  in the animal.  
     
     
         26 . The method as claimed in  claim 21 , wherein the animal is a human or livestock animal.  
     
     
         27 . The method as claimed in  claim 26 , wherein the livestock animal is a cow.

Join the waitlist — get patent alerts

Track US2008107602A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.